T1	Disorder 0 18	Torsade de pointes
N1 	Reference T1 UMLS:C0040479	Torsade de pointes
T2	Pharmacological_substance 50 60	droperidol
N1000 	Reference T2 MeSH:D004329	droperidol
T4	Pharmacological_substance 174 189	cyclobenzaprine
N1001 	Reference T4 MeSH:C004704	cyclobenzaprine
T5	Pharmacological_substance 194 204	fluoxetine
N1002 	Reference T5 MeSH:D005473	fluoxetine
T6	Pharmacological_substance 266 276	droperidol
N1003 	Reference T6 MeSH:D004329	droperidol
T7	Pharmacological_substance 337 347	fluoxetine
N1004 	Reference T7 MeSH:D005473	fluoxetine
T8	Pharmacological_substance 352 367	cyclobenzaprine
N1005 	Reference T8 MeSH:C004704	cyclobenzaprine
T9	Pharmacological_substance 496 506	droperidol
N1006 	Reference T9 MeSH:D004329	droperidol
T10	Disorder 588 606	torsade de pointes
N2 	Reference T10 UMLS:C0040479	torsade de pointes
T11	Disorder 630 654	ventricular fibrillation
N3 	Reference T11 UMLS:C0042510	ventricular fibrillation
T12	Pharmacological_substance 686 701	cyclobenzaprine
N1007 	Reference T12 MeSH:C004704	cyclobenzaprine
T14	Pharmacological_substance 763 778	Cyclobenzaprine
N1008 	Reference T14 MeSH:C004704	Cyclobenzaprine
T15	Disorder 811 822	tachycardia
N4 	Reference T15 UMLS:C0039231	tachycardia
T16	Pharmacological_substance 859 884	tricyclic antidepressants
N1009 	Reference T16 MeSH:D000929	tricyclic antidepressants
T17	Pharmacological_substance 886 890	TCAs
N1010 	Reference T17 MeSH:D000929	TCAs
T18	Pharmacological_substance 893 903	Fluoxetine
N1011 	Reference T18 MeSH:D005473	Fluoxetine
T25	Pharmacological_substance 1010 1013	TCA
N1012 	Reference T25 MeSH:D000929	TCA
T26	Pharmacological_substance 1055 1070	cyclobenzaprine
N1013 	Reference T26 MeSH:C004704	cyclobenzaprine
T27	Pharmacological_substance 1075 1085	fluoxetine
N1014 	Reference T27 MeSH:D005473	fluoxetine
T28	Disorder 1160 1178	torsade de pointes
N5 	Reference T28 UMLS:C0040479	torsade de pointes
T29	Pharmacological_substance 1198 1208	droperidol
N1015 	Reference T29 MeSH:D004329	droperidol
T30	Pharmacological_substance 1262 1277	cyclobenzaprine
N1016 	Reference T30 MeSH:C004704	cyclobenzaprine
T31	Disorder 1398 1416	torsade de pointes
N6 	Reference T31 UMLS:C0040479	torsade de pointes
T32	Pharmacological_substance 1504 1519	cyclobenzaprine
N1017 	Reference T32 MeSH:C004704	cyclobenzaprine
T33	Pharmacological_substance 1524 1534	fluoxetine
N1018 	Reference T33 MeSH:D005473	fluoxetine
T46	Disorder 1110 1125	QT prolongation
N7 	Reference T46 UMLS:C0151878	QT prolongation
T36	Disorder 130 145	QT prolongation
N8 	Reference T36 UMLS:C0151878	QT prolongation
T37	Combination 162 173	concomitant
T38	Subject 278 303	A 59-year-old white woman
T13	Disorder 232 250	torsade de pointes
N9 	Reference T13 UMLS:C0040479	torsade de pointes
T24	Disorder 828 839	dysrhythmic
T40	Coreferring_mention 475 486	the patient
T43	Speculation_cue 840 849	potential
T44	Combination 1040 1051	combination
T47	Manner_cue 1098 1109	significant
T48	Combination 1179 1184	after
T50	Disorder 1479 1490	dysrhythmic
T52	Speculation_cue 1491 1500	potential
